Lv1
50 积分 2022-12-30 加入
Combination of TAS-102 and bevacizumab as third-line treatment for metastatic colorectal cancer: TAS-CC3 study
7小时前
待确认
REOX: Evaluation of the efficacy of retreatment with an oxaliplatin-containing regimen in metastatic colorectal cancer: a retrospective single-center study
10小时前
已完结
转移性结直肠癌三线治疗的研究现状及进展
10小时前
已完结
Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm
1天前
已完结
Development of PI3Kα inhibitors for tumor therapy
5个月前
已完结
Preclinical Assessment of the PI3Kα Selective Inhibitor Inavolisib and Prediction of Its Pharmacokinetics and Efficacious Dose in Human
5个月前
已完结
Insulin–PI3K signalling: an evolutionarily insulated metabolic driver of cancer
6个月前
已完结
Metastatic Behavior of Breast Cancer Subtypes
6个月前
已完结
Ribociclib plus Endocrine Therapy in Early Breast Cancer
7个月前
已关闭
Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy
7个月前
已完结
皖公网安备34019202002308
